As per a PIB release, the performance of the device has been evaluated by the expert committee constituted by Director General of Health Services, Ministry of Health & Family Welfare, Government of India. The expert committee, after careful evaluation, has concluded that SwasthVayu may be used on COVID-19 patients who req... See more
The mathematical supermodel being used to forecast the dynamics of the Covid-19 pandemic in India has been making the correct predictions, said Shekhar Mande, director general at the Council of Scientific and Industrial Research (CSIR). The model has predicted that nearly 90 crore people may have alread... See more
A new study by laboratories in Hyderabad and Mohali has found fresh evidence that the risk of airborne transmission of the novel coronavirus is quite low if sufficient physical distance is maintained and prolonged interaction with an infected person is avoided. The transmission of SARS-CoV2 was initially thought to be ... See more
Amid concerns about a new coronavirus variant found in the United Kingdom (UK), Council of Scientific and Industrial Research (CSIR) Director-General Dr Shekhar Mande on Tuesday said that the mutation in the coronavirus will not affect vaccine development as vaccine invokes the overall immunity of the body. See more
The coronavirus vaccines will be equally effective against the new mutant of the virus and there is no reason to panic, Council for Scientific and Industrial Research Director General Shekhar Mande said on Monday. He said the transmissibility of the new strain N501Y is a "bit higher" but this does not mean it i... See more
Slamming a recent Chinese research report which claimed that Covid-19 had origins in India or Bangladesh, Council of Scientific and Industrial Research (CSIR) Director-General Dr Shekhar C Mande on Tuesday said that the study was shoddily done and was riddled with errors. See more
The Indian Council for Medical Research (ICMR) has approved a simple and fast method for COVID-19 testing which can not only increase the number of RT-PCR tests but can also bring down costs, the Council for Scientific and Industrial Research (CSIR) said on Saturday. See more
CSIR is uniquely placed as an S&T organization to deliver these at this critical juncture, having proven expertise in sequencing (first human genome sequencing), diagnostics for rare genetic diseases and being the fountain head of generic industry in the country.
CSIR has advantageously positioned itself to pursue the focused R&D to develop, integrate, scale-up, and deploy necessary technological interventions for combating Coronavirus pandemic in the country. Considering the multifarious problems created by coronavirus which require interventions in several areas and multi-pronged strategy, CSIR has set up five technology verticals for addressing the emerging situation due to pandemic.
These verticals are need based and span multiple research labs and disciplines and draw upon the strength of scientists, students and harness it for the fight against COVID-19. In addition, CSIR is also working on promoting rural employment and providing ready to eat food to migrants and other outreach programs.
Including digital methods: to understand the genetic basis and develop strategy to combat COVID-19
Rapid and economical Diagnostics: Kits based on DNA and serological basis to diagnose the virus at an early stage
Development of new therapies, including repurposing of drugs and new drugs: Vaccine development
Cheap Hospital assistive devices and Personal Protective Equipment (PPE)
Supply chain management and logistics with regard to availability of materials and resources.
CSIR being aware that the task is formidable and cannot be accomplished alone, is working in close synergy with other government departments, ministries and agencies on one hand and on the other is hand with Industry, MSMEs and others for scale up, delivery and implementation.
CSIR is working with various industries to develop technologies and products to fight against COVID-19. View all the Technologies & Products
A dynamic forum for exchanging views, opinions, experiences, and popular insights into developments, technologies & techniques related to COVID-19. Goto CSIR Covid19 Blog
CSIR calls for R&D Proposals from Industry and Start Ups under NMITLI Scheme for breakthrough technological interventions against COVID-19
List of projects selected against CSIR-NMITLI Call for Proposals for tackling COVID-19 Click here
CSIR's Societal Programs for mitigating Coronavirus Pandemic
Promoting Rural Entrepreneurship and Employment - with support from industry
distributed and transferred technology of making reusable face masks
produced and distributed hand sanitizers and disinfectants
Recent videos showcasing CSIR's work on COVID-19
A Short Video of CSIR Fights COVID-19
An Overview of Rational Drug Design by Dr. Shekhar Mande, DG CSIR and Secretary, DSIR
Webinar: CSIR Fights COVID-19: Computation to Testing and beyond (in Odia)
Webinar: Comprehensive approaches for mitigation of COVID-19 (in Malayalam)
Webinar: COVID - 19 and the North East | Role of CSIR (in Assamese)
Webinar: Testing, Prevention & Makeshift Hospitals: CSIR�s COVID-19 Footprints (in Tamil)
CSIR has its presence across India in the form of 38 laboratories working in difference technologies and sector. More details can be sought on CSIR website
Council of Scientific & Industrial Research,
Anusandhan Bhawan
2, Rafi Ahmed Kidwai Marg,
New Delhi 110 001
rpsingh@csir.res.in
